GlassScriptPhysician profile
Jill N Smith
NPI 1609180538
$1,274.70
in general payments reported to CMS, 2019-2025
19 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.93 · 2022: $227 · 2023: $234 · 2024: $312 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $147.31 | 2023-2025 | |
| Solventum Corporation | $145.73 | 2024-2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Kci USA, INC. | $119.55 | 2021-2023 | V.A.C. Veraflo, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Glaxosmithkline, LLC. | $105.24 | 2022 | |
| Baxter Healthcare | $92.68 | 2023-2025 | Hillrom - Centrella Smart+ Bed |
| Genmab U.S., INC. | $92.30 | 2023-2025 | Tivdak |
| Myriad Genetic Laboratories, INC. | $89.11 | 2024 | Precisetumor |
| Coloplast Corp | $81.89 | 2023-2025 | Triad |
| Molnlycke Health Care US, LLC | $81.34 | 2021-2025 | Mepilex, Mepilex Border Sacrum, Mepilex Border Flex |
| Convatec INC. | $80.54 | 2022-2025 | |
| Stemline Therapeutics INC. | $58.05 | 2023-2025 | Orserdu |
| Stryker Corporation | $44.33 | 2025 | Prevalon |
| Avanos Medical | $24.70 | 2025 | Pnb and Accessories |
| Sanara Medtech INC. | $20.91 | 2021 | |
| Acera Surgical, INC. | $18.90 | 2025 | Restrata Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $18.70 | 2024 | |
| Hydrofera LLC | $18.31 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.67 | 2025 | Ninlaro |
| Aveo Pharmaceuticals, INC. | $17.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.